IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $468,343 | -32.2% | 66,526 | -7.7% | 0.21% | -45.8% |
| Q3 2022 | $691,000 | +39.3% | 72,104 | +60.4% | 0.40% | +32.1% |
| Q2 2022 | $496,000 | -45.3% | 44,962 | -17.4% | 0.30% | -48.1% |
| Q1 2022 | $906,000 | -28.8% | 54,401 | -18.4% | 0.58% | -43.1% |
| Q4 2021 | $1,272,000 | -8.4% | 66,639 | +18.4% | 1.01% | +10.3% |
| Q3 2021 | $1,388,000 | +64.3% | 56,276 | +73.4% | 0.92% | +53.3% |
| Q2 2021 | $845,000 | +47.0% | 32,458 | +78.7% | 0.60% | +40.3% |
| Q1 2021 | $575,000 | -39.3% | 18,163 | -11.1% | 0.43% | -29.4% |
| Q4 2020 | $948,000 | +71.1% | 20,423 | +21.4% | 0.60% | +49.8% |
| Q3 2020 | $554,000 | +30.4% | 16,824 | +8.7% | 0.40% | +14.8% |
| Q2 2020 | $425,000 | – | 15,481 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |